Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Smoldering Multiple Myeloma 1 Prostatic Neoplasms 1 Osteoporosis 1 Oropharyngeal Neoplasms 1 Obesity 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Hypertension 1 Hypercholesterolemia 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Dexamethasone 33 Cyclophosphamide 28 Melphalan 26 Specimen Handling 24 Biopsy 24 Bortezomib 23 Magnetic Resonance Spectroscopy 17 Calcium Dobesilate 17 fludarabine phosphate 15 Lenalidomide 15 Filgrastim 15 Vincristine 12 Prednisone 12 Peripheral Blood Stem Cell Transplantation 12 sargramostim 9 dexamethasone acetate 9 dexamethasone 21-phosphate 9 carfilzomib 9 auricularum 9 Doxorubicin 9 fludarabine 8 Thalidomide 8 Interferon-alpha 7 Cyclosporine 7 Busulfan 7 trametinib 6 Rituximab 6 Etoposide 6 ixazomib 5 Sirolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Multiple Myeloma × Observation × Clear all

NCT00075829 2021-11-01

BMT CTN 0102

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

710 enrolled 19 charts

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡